Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/14/17 → 3/14/20 |
Funding
- INC Research, LLC (Prot #CA-170-101 // Prot #CA-170-101)
- Curis, Inc. (Prot #CA-170-101 // Prot #CA-170-101)
Prot #CA-170-101: A Phase 1, Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered CA-170 in Patients with Advanced Tumors and Lymphomas
- Sosman, Jeffrey Alan (PD/PI)
Project: Research project